What is Nostr?
Mike Malaska /
npub1v0m…w4tq
2025-01-05 19:49:26
in reply to nevent1q…jefe

Mike Malaska on Nostr: Sorry. I wasnt super-clear in explanation. Was assuming a total market potential of ...

Sorry. I wasnt super-clear in explanation.

Was assuming a total market potential of $1B per year, but assumed the successful drug would only capture 50% of that market averaged over 16 years.

So $500M per year actual sales over 16 years gives $8B total which is just enough to cover costs. No profit.

Means you need $1B per year potential to even think about a program.

(Which, as you stated, economocally limits targets.)
Author Public Key
npub1v0m8cmljfy9kze8fucetd2eqv3ptf7v9e092f8r5k2l0wpd485fs4vw4tq